Bio Pharma Dive

NOVEMBER 7, 2023

The biotech company creator hopes its new office will help its portfolio companies grow and strike partnerships in the region.

263

263

Fierce Pharma

NOVEMBER 30, 2023

we're highlighting two weeks' worth of biopharma news related to Asia. Because of the recent Thanksgiving holiday in the U.S., AstraZeneca in-licensed a KRAS G12D inhibitor from China's Usynova. BeiGene bought global rights to a CDK2 inhibitor in a deal worth up to $1.3 market at a 20% discount to Merck's Keytruda.

Licensing 98

Licensing Licensing Marketing 98

Pharma Mirror

OCTOBER 22, 2021

New Delhi, India, More than 50 per cent of the world’s hip fractures are expected to occur in the Asia Pacific by the year 2050. The post Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific appeared first on Pharma Mirror Magazine.

130

130

Fierce Pharma

SEPTEMBER 8, 2023

Three Japanese pharma companies lead our news stories from Asia this week. Astellas has abandoned its challenge against the Inflation Reduction Act. Astellas has abandoned its challenge against the Inflation Reduction Act. Otsuka bought a Canadian psychedelic biotech.

Pharma Companies 101

Pharma Companies Manufacturing 101

Pharma Mirror

MAY 7, 2022

. “The Singapore Manufacturing and Distribution Hub will enable Avantor to better serve the fast-growing Asia Pacific Biopharma market by facilitating shorter lead times, enhancing supply chain security.

Manufacturing 130

Manufacturing Life Science Production Marketing 130

Fierce Pharma

JANUARY 19, 2023

Fierce Pharma Asia—China's reimbursement round; Sun's alopecia bet; GenScript's CDMO raise aliu Thu, 01/19/2023 - 15:53

118

118

Medical Xpress

DECEMBER 31, 2022

Revelers began gathering in major city centers across the Asia-Pacific region to celebrate the first new year without COVID-19 restrictions since the pandemic began in 2020.

95

95

Fierce Pharma

APRIL 20, 2023

Fierce Pharma Asia—Carvykti's massive myeloma win; BeiGene's PD-1 comeback aliu Thu, 04/20/2023 - 15:00

105

105

Fierce Pharma

APRIL 4, 2024

Fierce Pharma Asia—Eisai's subQ Leqembi delay; Legend and J&J's supply deal with Novartis; China's Ozempic biosimilar aliu Thu, 04/04/2024 - 16:14

52

52

Fierce Pharma

MARCH 30, 2023

Fierce Pharma Asia—Takeda's manufacturing expansion; Leqembi's sales prospects; GSK's PrEP generics aliu Thu, 03/30/2023 - 16:18

Sales 98

Sales Manufacturing 98

Fierce Pharma

MAY 18, 2023

Fierce Pharma Asia—Takeda's 'challenging' year; AZ's cancer buy; Astellas' menopause drug nod aliu Thu, 05/18/2023 - 22:47

Drugs 98

Drugs 98

Outsourcing Pharma

JULY 6, 2023

This yearâs CPHI South East Asia is expecting a surge in international partnering with organizers expecting a record attendance of 8,000 visitors including a significant number from overseas â doubling last yearâs figures.

Drugs 97

Drugs Regulation Marketing 97

Fierce Pharma

MAY 26, 2023

Fierce Pharma Asia—Carvykti's EU filing; Thermo Fisher's Singapore expansion; Celltrion's Humira biosim nod aliu Fri, 05/26/2023 - 08:43

95

95

Fierce Pharma

JUNE 8, 2023

Fierce Pharma Asia—Eisai and Biogen's Leqembi progress; AZ and Daiichi's Enhertu data; Samsung Biologics' manufacturing deal zbecker Thu, 06/08/2023 - 19:34

Manufacturing 98

Manufacturing 98

Fierce Pharma

APRIL 6, 2023

Fierce Pharma Asia—BioNTech's ADC deal; Sanofi's potential consumer cut; Takeda's latest celiac play aliu Thu, 04/06/2023 - 15:39

98

98

Fierce Pharma

MARCH 23, 2023

Fierce Pharma Asia—Takeda's $4B psoriasis data; Biohaven's neurology bet; Pfizer and Astellas' Xtandi wins aliu Thu, 03/23/2023 - 18:29

97

97

Fierce Pharma

JANUARY 26, 2023

Fierce Pharma Asia—Takeda's cancer deal; BeiGene's Brukinsa nod; Astellas' gene therapy reprieve aliu Thu, 01/26/2023 - 14:58

Gene Therapy 94

Gene Therapy Gene 94

Pharmaceutical Technology

APRIL 5, 2024

GSK’s Trelegy Ellipta has been approved as a maintenance therapy for both asthma and COPD in Singapore.

130

130

Scienmag

NOVEMBER 10, 2021

For large parts of eastern Asia however, the […]. With the impacts of climate change now increasingly hitting parts of the world in the form of, for example, the extreme heatwaves in Canada and Italy, and the severe floods in Europe and China, 2021 has been a year of new records and fear for the future.

92

92

Fierce Pharma

DECEMBER 2, 2022

Fierce Pharma Asia—Eisai's lecanemab Alzheimer's debate; BeiGene's Imbruvica showdown; Shionogi's COVID drug nod. Fri, 12/02/2022 - 08:55.

Drugs 97

Drugs 97

Fierce Pharma

MARCH 2, 2023

Fierce Pharma Asia—Samsung's deal with Pfizer; Olympus' and Dr. Reddy's M&A moves; BeiGene's growth aliu Thu, 03/02/2023 - 15:58

98

98

Pharma Mirror

MAY 7, 2022

. “The Singapore Manufacturing and Distribution Hub will enable Avantor to better serve the fast-growing Asia Pacific Biopharma market by facilitating shorter lead times, enhancing supply chain security.

Manufacturing 100

Manufacturing Life Science Production Marketing 100

Pharmaceutical Technology

JULY 28, 2022

Here are Asia Pacific’s five largest chemical and pharmaceutical construction projects that were initiated in Q2 2022, according to GlobalData’s construction projects database. The main aim is to produce innovative vaccines on a massive scale for Asia and respond to future pandemic risks.

Manufacturing 100

Manufacturing Vaccination Vaccine Production 100

Fierce Pharma

NOVEMBER 18, 2022

Fierce Pharma Asia—BioNTech, GSK grow in Singapore; Astellas' stomach cancer win; Daiichi's mRNA vaccine readout. Fri, 11/18/2022 - 09:44.

Vaccination 98

Vaccination Vaccine 98

Fierce Pharma

FEBRUARY 2, 2023

Fierce Pharma Asia—J&J, Legend's CAR-T win; Sanofi's India job cuts; BeiGene, Novartis' PD-1 delay aliu Thu, 02/02/2023 - 15:58

104

104

Fierce Pharma

JANUARY 6, 2023

Fierce Pharma Asia—Eisai’s Alzheimer’s trial deaths; Moderna’s first M&A deal; GSK, WuXi's bispecific pact. Fri, 01/06/2023 - 10:36.

Trials 94

Trials 94

Pharmaceutical Technology

JANUARY 26, 2024

Renalys plans to start a registrational trial for sparsentan as a treatment for IgA nephropathy in Japan in Q2 2024.

Licensing 147

Licensing Licensing Trials 147

BioPharma Reporter

SEPTEMBER 5, 2022

The Asia-Pacific (APAC) region was the largest contributor to the global clinical trial landscape from 2017 to 2021, accounting for more than 50% of conducted trials during the analysis period, found research by GlobalData.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Research 59

Scienmag

OCTOBER 31, 2021

Asia-Pacific Climate Change Adaptation Information Platform (AP-PLAT) website is accessible at [link] Credit: CCCA, NIES Asia-Pacific Climate Change Adaptation Information Platform (AP-PLAT) website is accessible at [link] 1.

Development 80

Development 80

Pharma Focus Asia

MARCH 21, 2022

The post How To Improve Pharma Care In South-East Asia first appeared on Pharma Focus Asia. The provision of medicine to a person who desperately needs it could, quite literally, be the difference between life and death for that person, which is one of the main reasons why effective pharma care is so important.

Medicine 52

Medicine 52

BioPharma Reporter

MAY 31, 2023

mRNA technology is a âgame-changerâ for Asia-Pacific (APAC) vaccine manufacturers, according to a new report by science and technology company Merck.

Manufacturing 52

Manufacturing Vaccination Vaccine Development 52

Scienmag

APRIL 7, 2022

Through a shared commitment to transforming cardiovascular care, the American College of Cardiology is partnering with the Korean Society of Cardiology (KSC) to host ACC Asia 2022 Together with KSC Spring Conference, taking place April 15-16, 2022, in Gyeongju, South Korea and virtually. Led by conference co-chairs Fred M.

Cardiology 56

Cardiology 56

Fierce Pharma

APRIL 27, 2023

Fierce Pharma Asia—Daiichi's leukemia delay, Enhertu gains; Glenmark's settlement aliu Thu, 04/27/2023 - 22:47

52

52

The Pharma Data

JULY 2, 2023

Syneos Health Strengthens Asia Pacific Leadership Syneos Health ® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced Shigeto Miyamoto as Vice President of Digital Solutions for Asia Pacific.

Sales 40

Sales Marketing Pharma Companies Development 40

Fierce Pharma

MAY 11, 2023

Fierce Pharma Asia—Roche, Eisai's HER2 deals; Takeda's layoffs in the US aliu Thu, 05/11/2023 - 15:14

58

58

Scienmag

MARCH 24, 2022

At least 40 percent of global rice exports come from Southeast Asia, making the region a major rice bowl. The region helps feed other parts of the world such as Africa and the Middle East. Projections show that global rice demand is set to increase by 30 percent by 2050. With the continuing rice trade […].

65

65

Fierce Pharma

FEBRUARY 23, 2023

Fierce Pharma Asia—Eisai's Leqembi hurdle; AZ's cancer deal; and Mitsubishi's royalty win aliu Thu, 02/23/2023 - 15:26

58

58